Most patients view their test results before their doctor, with some reporting low comprehension
You get a message that a test result is available in your online patient portal. Do you look at it right away, or do you wait to hear… read more.
You get a message that a test result is available in your online patient portal. Do you look at it right away, or do you wait to hear… read more.
The NHS 10 year Health Plan “risks propagating patient harm at an unprecedented scale” due to the lack of appropriate safety architecture to support the envisaged digital transformation,… read more.
Gilead Sciences, Inc. announced that the EC has granted marketing authorization for Trodelvy (sacituzumab govitecan-hziy) in combination with Keytruda (pembrolizumab) for the treatment of adult patients with unresectable,… read more.
University of Birmingham scientists have developed a new material that changes from a gel to a liquid-like state under ultraviolet light and can be rebuilt using heat or… read more.
Wearable sensors coupled with AI can generate blood pressure readings nearly as well as the invasive and risky arterial lines relied on in intensive care units and operating… read more.
Monash University researchers have reviewed existing evidence and concluded that most shoulder problems get better with self-management, education and time, challenging widespread clinical reliance on early imaging and… read more.
Insmed Incorporated announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Brinsupri (brensocatib 25-mg tablet), an oral, once-daily treatment for non-cystic fibrosis bronchiectasis (NCFB) in… read more.
Emergency Medicine & Intensive Care
Airline emergency medical kits should include benzodiazepines so that cabin crew and responding clinicians can treat passengers who have a seizure mid-flight, according to a Viewpoint published in… read more.
Takeda announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of Orzeyful (oveporexton) for the treatment of narcolepsy type 1 (NT1, narcolepsy with… read more.
Personal care products are among the largest everyday sources of exposure to endocrine-disrupting chemicals, and high schoolers who follow social media influencers or watch beauty tutorials seem to… read more.
Regeneron Pharmaceuticals, Inc. announced the FDA has granted approval for Pasatru (garetosmab-grts) to reduce formation of new heterotopic ossification (HO) lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans… read more.
For sleep-deprived nursing moms, artificial intelligence may feel like a lifeline. In fact, a new national survey from Orlando Health reveals if women ages 18 to 44 had an urgent… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.